Grant: Project Grant
Université Laval
$1,002,150.00
Dissecting the role of the gut microbiota and the gut-liver axis in dysmetabolim induced by high fructose intake.
FY 2024-25
Summary
Consuming excessive fructose, either directly or as part of sucrose (table sugar), can lead to a fatty liver and high blood sugar. One concern is that too much fructose might increase gut fat absorption, but we are not sure how it affects the absorption of glucose, the primary source of energy for our bodies. We know the gut microbiota (the community of bacteria living in our intestines) can modulate gut glucose absorption. We think the gut microbiota during high fructose influences the gut's capacity to absorb glucose, which can contribute to problems like fatty liver and diabetes.
We know that some of the excess fructose ends up in the liver, but it also accumulates in the lower part of the small intestine and colon. Here, gut bacteria break down fructose into various products. We still do not understand how these microbial by-products of fructose can cause metabolic disease.
Our research involves using mice to study the effects of a high-fructose diet. We have found that excessive fructose can enlarge the surface area of the gut, leading to increased glucose absorption, high blood sugar, and a fatty liver. We will now examine different sections of the intestine to see how the gut microbiota and the structures involved in sugar absorption change in these mice.
To further explore the role of the microbiota, we will transfer the bacteria from high-fructose-fed mice to mice without any bacteria. This will help us determine if the microbiota alone can contribute to fatty liver and high blood sugar. Additionally, we'll use labeled fructose to track how the bacterial by-products of fructose are used by the body.
Our research will shed light on how gut bacteria can link excessive fructose consumption to metabolic problems. Our work will lay the groundwork for new gut microbiota-based strategies to fight diabetes and fatty liver disease.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
508055
Name
Forato Anhê Fernando
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
Dissecting the role of the gut microbiota and the gut-liver axis in dysmetabolim induced by high fructose intake.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$1,002,150
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Blood Glucose; Gut Function; Gut Microbiota; Obesity; Type 2 Diabetes
Abstract
Consuming excessive fructose, either directly or as part of sucrose (table sugar), can lead to a fatty liver and high blood sugar. One concern is that too much fructose might increase gut fat absorption, but we are not sure how it affects the absorption of glucose, the primary source of energy for our bodies. We know the gut microbiota (the community of bacteria living in our intestines) can modulate gut glucose absorption. We think the gut microbiota during high fructose influences the gut's capacity to absorb glucose, which can contribute to problems like fatty liver and diabetes.
We know that some of the excess fructose ends up in the liver, but it also accumulates in the lower part of the small intestine and colon. Here, gut bacteria break down fructose into various products. We still do not understand how these microbial by-products of fructose can cause metabolic disease.
Our research involves using mice to study the effects of a high-fructose diet. We have found that excessive fructose can enlarge the surface area of the gut, leading to increased glucose absorption, high blood sugar, and a fatty liver. We will now examine different sections of the intestine to see how the gut microbiota and the structures involved in sugar absorption change in these mice.
To further explore the role of the microbiota, we will transfer the bacteria from high-fructose-fed mice to mice without any bacteria. This will help us determine if the microbiota alone can contribute to fatty liver and high blood sugar. Additionally, we'll use labeled fructose to track how the bacterial by-products of fructose are used by the body.
Our research will shed light on how gut bacteria can link excessive fructose consumption to metabolic problems. Our work will lay the groundwork for new gut microbiota-based strategies to fight diabetes and fatty liver disease.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Forato Anhê, Fernando
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,002,150~ $0~